Copycat biotech cancer drug works as well as Roche original -study

June 3 (Reuters) - A copycat version of Roche Holding AG's

breast cancer drug Herceptin worked as well, and as

safely, as the original biotechnology treatment in the

first-ever study to compare such a "biosimilar" to a brand-name

drug.

Read more